Floatz logo

Cranberry

Urinary Tract Infection

Rennes University HospitalUNKNOWNPhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Urinary Tract Infection cohort.

Asset / SponsorPhaseRating
Normal Human Serum Albumin
EASL - CLIF Consortium
Phase 4BB
Allocetra-Ots
Enlivex Therapeutics Ltd.
Phase 2CCC
Cotrimoxazole
Indonesia University
Phase 2CC
Lactobacillus Rhamnosus Gg
Medstar Health Research Institute
Early Phase 1C
Gentamicin
Medstar Health Research Institute
Early Phase 1C

View all 9 →

Same molecule, other indications

Cranberry is also rated in:

urinary bladder disorderDormant
B
Indicative · Phase 3
62 / 100
View asset →
multiple sclerosisDormant
CCC
Indicative · Phase 3
53 / 100
View asset →
inflammatory diseaseDormant
D
Indicative · N/A
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →